Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
1.
Breast cancer: A new target to eliminate dormant cells before they wake
2.
The clinical trial of ENZAMET shows promise as a treatment for prostate cancer.
3.
Potentially Novel Approach for Treating Advanced Colorectal Cancer with KRAS Mutations.
4.
Liver cancer cells under pressure: Compression can spark invasion, drug resistance and altered gene activity
5.
A smartphone app enhances the tracking of recovery following breast and gynecologic oncology surgery, according to JAMA.
1.
Generative AI for Adaptive Oncology Trial Design
2.
Immune Surveillance Screening for Early Cancer Risk Detection
3.
Machine Learning in Genomic Analysis for Early Lung Cancer Detection: Key Advances and Insights
4.
Comprehensive Developments in Hematology in Daily Practice
5.
Uncovering the Reality of Colon Cancer: A Look at Real Images
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias
2.
Efficient Management of First line ALK-rearranged NSCLC - Part V
3.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part IV
4.
First-Line Maintenance Therapy for Metastatic Urothelial Carcinoma: Bridging Clinical Practice and Trials
5.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
Recommended News For You
1.
Pirtobrutinib Delays Progression in CLL Already Treated With a BTK Inhibitor
2.
Pain’s Toll: Frailty Risk for Childhood Cancer Survivors
3.
Children living near oil and gas wells face higher risk of rare leukemia, studies show
4.
Artificial intelligence is assisting in the earlier detection and treatment of breast cancer.
5.
An inhibitor of JAK1 exhibits "remarkable" activity in T-cell lymphoma.
Conferences That Might Interest You
Recommended Articles For You
1.
Evidence-Based Insights in Oncology for Specialists
2.
Revolutionizing Cancer Care: The Transformative Role of AI and Data Science in Oncology
3.
Targeting the Tumor Microenvironment: Next-Generation Strategies for Immuno-Oncology Success
4.
Optimizing Platelet Transfusions: Balancing Benefits and Risks in Modern Hematology
5.
All You Need To Know About Partial Thromboplastin Time (PTT) Test
Boost Your Knowledge With These Quizzes
1.
Quiz on Treatment Strategies for Osteoporosis in Rheumatologic Disorders: Are You Aware of the Latest Challenges in Managing Bone Health?
2.
Quiz on Methanol Poisoning
3.
Quiz on Non-Vitamin K Antagonist Oral Anticoagulants (NOACs) in Venous Thromboembolism
4.
Quiz on PNH Treatment Breakthroughs: C5 Inhibitors & Emerging Therapies
5.
Quiz on Surviving the Cure: Managing Long-Term Toxicities of Cancer Treatments
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge